Correction: Clinical characteristics of systemic lupus erythematosus patients in long-term remission without treatment
- PDF / 139,436 Bytes
- 1 Pages / 595.276 x 790.866 pts Page_size
- 76 Downloads / 164 Views
CORRECTION
Correction: Clinical characteristics of systemic lupus erythematosus patients in long-term remission without treatment J. Jakez-Ocampo 1
&
M. Rodriguez-Armida 2 & H. Fragoso-Loyo 1 & G. Lima 1 & L. Llorente 1 & Y. Atisha-Fregoso 3,4
Published online: 23 September 2020 # International League of Associations for Rheumatology (ILAR) 2020
Correction to: Clinical Rheumatology https://doi.org/10.1007/s10067-020-05379-8
The original published version of the above article contained errors in Key Points and Conclusion sections. The authors requested that these be noted [Bold text used to highlight problem area]. Key Points section it should read as follows: • SLE patients can reach a very prolonged state of remission, free of treatment, including antimalarials, for at least 10 years. • Thrombocytopenia and alopecia were more commonly present and an inflammatory rash was less frequent in patients that achieved remission. • Notwithstanding the presence of serological markers of activity, some patients achieved 10 years in remission free of treatment.
The online version of the original article can be found at https://doi.org/ 10.1007/s10067-020-05379-8 * J. Jakez-Ocampo [email protected] * Y. Atisha-Fregoso [email protected] 1
Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
2
Department of Internal Medicine, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
3
Elmezzi Graduate School of Molecular Medicine, Manhasset, NY, USA
4
Institute of MolecularMedicine, The Feinstein Institutes for Medical Research, Manhasset, NY, USA
Instead of: • SLE patients can reach a very prolonged state of remission, free of treatment, including antimalarials, for at least ten years. • Venous thromboembolism and thrombocytopenia are commonly present in patients that achieved remission. • The presence of serological markers of activity, even after 10 years in remission, is a risk factor for relapse. Conclusions it should read as follows: Although patients with SLE who achieve prolonged remission have some different characteristics at baseline compared with PtAct, it‘s not possible to identify a characteristic phenotype for the former. Achieving a state of prolonged remission or low disease activity should always be the goal in patients with SLE. Instead of: Although patients with SLE who achieve prolonged remission have some different characteristics at baseline compared with PtAct, it‘s not possible to identify a characteristic phenotype for the former. Achieving a state of prolonged remission should always be the goal in patients with SLE. Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Data Loading...
